AI-guided light analysis could help assess skin cancer and reduce unnecessary biopsies

Skin cancer is the most common cancer in the United States and among the most common worldwide. Nearly 1.5 million new cases were diagnosed globally in 2024, including nearly 340,000 melanomas. Nonmelanoma skin cancers—primarily basal cell carcinoma (BCC) and squamous cell carcinoma (SCC)—are even more common, with 5.4 million cases diagnosed annually in the U.S.

≈